|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-4-12
|
|
pubmed:abstractText |
SDZ ASM 981 is a selective inhibitor of the production of pro-inflammatory cytokines from T cells and mast cells in vitro. It is the first ascomycin macrolactam derivative under development for the treatment of inflammatory skin diseases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
pubmed-author:Berth-JonesJJ,
pubmed-author:BjerkeJJ,
pubmed-author:BosJ DJD,
pubmed-author:ChristophersEE,
pubmed-author:GraeberMM,
pubmed-author:HedgecockSS,
pubmed-author:KandraAA,
pubmed-author:KnoxBB,
pubmed-author:KnulstA CAC,
pubmed-author:LugerTT,
pubmed-author:MorrenMM,
pubmed-author:MorrisAA,
pubmed-author:ReitamoSS,
pubmed-author:Roed-PetersenJJ,
pubmed-author:SchoepfEE,
pubmed-author:Thestrup-PedersenKK,
pubmed-author:ThurstonMM,
pubmed-author:Van Der ValkP GPG,
pubmed-author:Van LeentE JEJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
144
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
788-94
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11298538-Adolescent,
pubmed-meshheading:11298538-Adult,
pubmed-meshheading:11298538-Aged,
pubmed-meshheading:11298538-Dermatitis, Atopic,
pubmed-meshheading:11298538-Dermatologic Agents,
pubmed-meshheading:11298538-Dose-Response Relationship, Drug,
pubmed-meshheading:11298538-Double-Blind Method,
pubmed-meshheading:11298538-Female,
pubmed-meshheading:11298538-Humans,
pubmed-meshheading:11298538-Male,
pubmed-meshheading:11298538-Middle Aged,
pubmed-meshheading:11298538-Severity of Illness Index,
pubmed-meshheading:11298538-Tacrolimus,
pubmed-meshheading:11298538-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis.
|
|
pubmed:affiliation |
Department of Dermatology, University of Muenster, Germany. luger@uni-muenster.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
